Incidence and Prevalence of Patients with Myelodysplastic Syndromes (MDS) in Dusseldorf 1996-2005

被引：0
|
作者：
Neukirchen, J. [1 ]
Germing, U. [1 ]
Aul, C. [2 ]
Gattermann, N. [1 ]
Schoonen, M. [3 ]
Haas, R. [1 ]
机构：
[1] Univ Dusseldorf, Klin Hamatol Onkol & Klin Immunol, D-4000 Dusseldorf, Germany
[2] St Johannes Hosp Duisburg, Med Klin 2, Duisburg, Germany
[3] Amgen Ltd, Cambridge, England
来源：
MEDIZINISCHE KLINIK | 2010年 / 105卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：212 / 213
页数：2
相关论文
共 50 条
  • [31] Combination of thalidomide and Enbrel for the treatment of patients with myelodysplastic syndromes (MDS).
    Raza, A
    Dutt, D
    Lisak, L
    Dean, L
    Fantroy, L
    Gezer, S
    Syed, E
    Goldberg, C
    Loew, J
    Hsu, WT
    Venugopal, P
    BLOOD, 2001, 98 (11) : 273B - 274B
  • [32] Prevalence and complications associated with off-label use of lenalidomide in older patients with myelodysplastic syndromes (MDS).
    Brunner, Andrew Mark
    Weng, Shicheng
    Cronin, Angel M.
    Fathi, Amir Tahmasb
    Stone, Richard M.
    Graubert, Timothy A.
    Steensma, David P.
    Abel, Gregory A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) - update of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Sauer, A.
    Buschmann, D.
    Germing, U.
    Severin, K.
    Steinmetz, H. T.
    ONKOLOGIE, 2013, 36 : 242 - 242
  • [34] Improvement in cytopenias of patients with myelodysplastic syndromes (MDS) in response to thalidomide
    Raza, A
    Lisak, L
    Little, L
    Andrews, C
    Meyer, P
    Ekbal, M
    Venugopal, P
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 103 - 104
  • [35] THE IMPACT OF MYELODYSPLASTIC SYNDROMES (MDS) ON THE MENTAL HEALTH OF PATIENTS AND CAREGIVERS
    Scheurmeyer, Isabel
    Hughes, Mary
    Sloan, Erika
    LeBlanc, Thomas
    Houk, Alice
    Sirewu, Nyaradzo
    ONCOLOGY NURSING FORUM, 2024, 51 (02)
  • [36] Re: "Trends in Asthma Prevalence and Incidence in Ontario, Canada, 1996-2005: A Population Study" (vol 172, pg 728, 2010)
    Gershon
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 (08) : 970 - 970
  • [37] Risk factors for death among patients in French Guiana:: 1996-2005
    Nacher, M.
    Huber, F.
    El Guedj, M.
    Vaz, T.
    Magnien, C.
    Djossou, F.
    Randrianjohany, A.
    Alvarez, F.
    Couppie, P.
    HIV MEDICINE, 2007, 8 (07) : 472 - 474
  • [38] Prevalence of and intrinsic risk factors for appendicular osteosarcorna in dogs: 179 cases (1996-2005)
    Rosenberger, Julie A.
    Pablo, Norma V.
    Crawford, P. Cynda
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2007, 231 (07): : 1076 - 1080
  • [39] Incidence of myelodysplastic syndromes (MDS) in the geographically defined area of south-western Greece
    Schoonen, W.
    Aagnes, B.
    Bray, F.
    Hansen, S.
    Fryzek, J.
    Weiderpass, E.
    LEUKEMIA RESEARCH, 2009, 33 : S64 - S65
  • [40] Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996-2005: a national population-based study
    Chien, I-Chia
    Lin, Ching-Heng
    Chou, Yiing-Jenq
    Chou, Pesus
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2012, 47 (12) : 1885 - 1890
12345